Skip to main content
Log in

Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the risk factors and efficacy of a povidone-iodine enema on infectious complications after transrectal ultrasound-guided prostate biopsy.

Methods

A total of 814 males who underwent transrectal ultrasound-guided prostate biopsy from January 2011 to December 2013 were evaluated retrospectively. Clinical variables, including demographics, prior antibiotic, or quinolone exposure, rectal swab culture results, povidone-iodine rectal cleansing, antibiotic prophylaxis, and infectious complications, were evaluated.

Results

Overall, 16 of 814 (2.0 %) patients developed infectious complications after prostate biopsy. Of the patients with infectious complications, five had fever, two had urinary tract infections, and nine had bacteremia or sepsis. Infectious complication rates were not significantly different between povidone-iodine rectal cleansing (n = 613) and no cleansing (n = 201) groups (1.5 vs. 3.5 %, p = 0.083). However, povidone-iodine rectal cleansing reduced severe infectious complications such as bacteremia and sepsis (0.3 vs. 3.5 %, p = 0.001). A rectal swab culture was performed in 552 patients, and extended-spectrum β-lactamase (ESBL)-producing and quinolone-resistant Escherichia coli were detected in 4.5 and 7.8 % of cultures, respectively. Quinolone and antibiotic exposure within 6 months prior to prostate biopsy were associated with quinolone resistance and ESBL positivity of rectal flora and infectious complications.

Conclusions

In the era of quinolone resistance, a povidone-iodine enema may reduce the infectious complication rate by reducing bacterial load. Quinolone exposure prior to prostate biopsy was a risk factor for antibiotic resistance to rectal flora and infectious complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bootsma AM, Pes MPL, Geerlings SE, Goossens A (2008) Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 54:1270–1286

    Article  PubMed  Google Scholar 

  2. Zani EL, Clark OA, Jr Rodrigues Netto N (2011) Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev 5:CD006576

    PubMed  Google Scholar 

  3. Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Paterson DL (2014) Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis 57:267–274

    Article  Google Scholar 

  4. Drusano GL, Preston SL, Van Guilder M et al (2000) A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrob Agents Chemother 44:2046–2051

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2011) Complications after prostate biopsy: data from SEER-Medicare. J Urol 186:1830–1834

    Article  PubMed  Google Scholar 

  6. Nam RK, Saskin R, Lee Y et al (2010) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 183:963–968

    Article  PubMed  Google Scholar 

  7. Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schroder FH, Roobol MJ (2012) Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61:1110–1114

    Article  PubMed  Google Scholar 

  8. Steensels D, Slabbaert K, De Wever L, Vermeersch P, Van Poppel H, Verhaegen J (2012) Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy—should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18:575–581

    Article  CAS  PubMed  Google Scholar 

  9. Taylor AK, Zembower TR, Nadler RB et al (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 187:1275–1279

    Article  CAS  PubMed  Google Scholar 

  10. Abughosh Z, Margolick J, Goldenberg SL et al (2013) A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 189:1326–1331

    Article  CAS  PubMed  Google Scholar 

  11. Liss MA, Chang A, Santos R et al (2011) Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 185:1283–1288

    Article  PubMed Central  PubMed  Google Scholar 

  12. Duplessis CA, Bavaro M, Simons MP et al (2012) Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology 79:556–561

    Article  PubMed  Google Scholar 

  13. Taylor S, Margolick J, Abughosh Z et al (2013) Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int 111:946–953

    Article  CAS  PubMed  Google Scholar 

  14. Kim JB, Jung SI, Hwang EC, Kwon DD (2014) Prevalence of antibiotic-resistant bacteria on rectal swabs and factors affecting resistance to antibiotics in patients undergoing prostate biopsy. Korean J Urol 55:201–206

    Article  PubMed Central  PubMed  Google Scholar 

  15. Akduman B, Akduman D, Tokgoz H et al (2011) Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology 78:250–255

    Article  PubMed  Google Scholar 

  16. Mosharafa AA, Torky MH, El Said WM, Meshref A (2011) Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology 78:511–514

    Article  PubMed  Google Scholar 

  17. Patel U, Dasgupta P, Amoroso P, Challacombe B, Pilcher J, Kirby R (2012) Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int 109:1781–1785

    Article  PubMed  Google Scholar 

  18. Park DS, Oh JJ, Lee JH, Jang WK, Hong YK, Hong SK (2009) Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy. Adv Urol 2009:750598. doi:10.1155/2009/750598

    Article  PubMed Central  Google Scholar 

  19. Park DS, Hwang JH, Choi DK et al (2014) Control of infective complications of transrectal prostate biopsy. Surg Infect 15:431–436

    Article  Google Scholar 

  20. Ghafoori M, Shakiba M, Seifmanesh H, Hoseini K (2012) Decrease in infection rate following use of povidone-iodine during transrectal ultrasound guided biopsy of the prostate: a double blind randomized clinical trial. Iran J Radiol 9:67–70

    Article  PubMed Central  PubMed  Google Scholar 

  21. Wolf JS Jr, Bennett CJ, Dmochowski RR et al (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179:1379–1390

    Article  PubMed  Google Scholar 

  22. Workman ML (1995) Comparison of blot-drying versus air-drying of povidone-iodine—cleansed skin. Appl Nurs Res 8:15–17

    Article  CAS  PubMed  Google Scholar 

  23. Atiyeh BS, Dibo SA, Hayek SN (2009) Wound cleansing, topical antiseptics and wound healing. Int Wound J 6:420–430

    Article  PubMed  Google Scholar 

  24. Noorani A, Rabey N, Walsh SR, Davies RJ (2010) Systematic review and meta-analysis of preoperative antisepsis with chlorhexidine versus povidone-iodine in clean-contaminated surgery. Br J Surg 97:1614–1620

    Article  CAS  PubMed  Google Scholar 

  25. Madden T, Doble A, Aliyu SH, Neal DE (2011) Infective complications after transrectal ultrasound-guided prostate biopsy following a new protocol for antibiotic prophylaxis aimed at reducing hospital-acquired infections. BJU Int 108:1597–1602

    Article  CAS  PubMed  Google Scholar 

  26. Wagenlehner FM, van Oostrum E, Tenke P et al (2013) Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63:521–527

    Article  PubMed  Google Scholar 

  27. Tal R, Livne PM, Lask DM, Baniel J (2003) Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy. J Urol 169:1762–1765

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was financially supported by a Grant (2013-0707) Chonnam National University, Republic of Korea.

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seung Il Jung.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hwang, E.C., Jung, S.I., Seo, Y.H. et al. Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study. Int Urol Nephrol 47, 595–601 (2015). https://doi.org/10.1007/s11255-015-0931-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-015-0931-2

Keywords

Navigation